Myriad Genetics ex-Chief Commercial Officer Brian Donnelly exits company under separation agreement

Bitget2026/10/09 20:17

Myriad Genetics disclosed the departure of Chief Commercial Officer Brian Donnelly, effective Sept. 16, 2026. Donnelly’s employment ended at the close of business on Sept. 21, 2026, under a separation agreement dated Oct. 6, 2026. The agreement includes accelerated vesting for certain time-based equity awards over a two-year period from the separation date. Performance-based equity awards remain outstanding, with potential vesting tied to results achieved within two years of the separation date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myriad Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000899923-26-000084), on October 09, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Myriad Genetics disclosed the departure of Chief Commercial Officer Brian Donnelly, effective Sept. 16, 2026.
Donnelly’s employment ended at the close of business on Sept. 21, 2026, under a separation agreement dated Oct. 6, 2026.
The agreement includes accelerated vesting for certain time-based equity awards over a two-year period from the separation date.
Performance-based equity awards remain outstanding, with potential vesting tied to results achieved within two years of the separation date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myriad Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000899923-26-000084), on October 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Myriad Genetics ex-Chief Commercial Officer Brian Donnelly exits company under separation agreement

You may also like

Crypto prices